The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:IndexIQ and MainStay Are Email Routing List Email & Route  Print Print
Monday, December 08, 2014

IndexIQ and MainStay Are "Right In Sync"

Reported by Neil Anderson, Managing Editor

Adam Patti and his team are staying put.

Patti, CEO and co-founder of eight-year-old IndexIQ [profile], confirms that his "full team" of 18 people is coming to New York Life's MainStay [profile] arm when the deal closes in the first half of 2015. New York Life Investment Management chief Drew Lawton unveiled the deal last week.

"It's a growth story," Patti tells MFWire, noting that IndexIQ's ETF efforts will provide another platform for broadening NYLIM's business. "If anything we're going to be building, certainly not cutting."

IndexIQ will keep its brand as part of MainStay's multi-boutique model, Patti says. Yet the IndexIQ products (currently 11 ETFs and 1 traditional mutual fund) will shift to a combined brand, MainStayIQ.

"Culturally and vision-wise we're right in sync," Patti says. "That's one of the beautiful things about this relationship."

Looking forward, Patti sees the second phase of growth in the ETF market as being in more sophisticated ETF products (as opposed to the original ETFs that tracked extremely broad, famous indexes). And that sophisticated end of the ETF business is where IndexIQ has planted its flag. 

Stay ahead of the news ... Sign up for our email alerts now

 Do You Recommend This Story?

Return to Top
 News Archives
2021: Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Add to My Yahoo!
follow us in feedly

©All rights reserved to InvestmentWires, Inc. 1997-2021
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use